Gabriel C. Léger

Also affiliated with Alzheimer’s Disease Neuroimaging Initiative, Association for Language Learning

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 11 papers. Top paper: “Proposed research criteria for prodromal behavioural variant frontotemporal dementia”.

Proposed research criteria for prodromal behavioural variant frontotemporal dementia

Brain(2021)10.1093/brain/awab365

N/A

0.698DataRank · unranked

104 citations

Reena Gottesman, Masood Manoochehri, Silvia Chapman, Brian S. Appleby, Danielle Brushaber +37 more

Comprehensive cross-sectional and longitudinal analyses of plasma neurofilament light across FTD spectrum disorders

Cell Reports Medicine(2022)10.1016/j.xcrm.2022.100607

N/A

0.641DataRank · unranked

71 citations

Michael G. Heckman, Launia J. White, Austin M. Veire, Otto Pedraza, Alexander R. Burch +77 more

Varoglutamstat: Inhibiting Glutaminyl Cyclase as a Novel Target of Therapy in Early Alzheimer’s Disease

Journal of Alzheimer s Disease(2024)10.3233/jad-231126

N/A

0.522DataRank · unranked

17 citations

for the ADCS VIVA-MIND Study Group, Karen Messer, Yuqi Qiu, Marwan Sabbagh, Douglas Galasko +16 more

Multisite ALLFTD study modeling progressive empathy loss from the earliest stages of behavioral variant frontotemporal dementia

Alzheimer s & Dementia(2023)10.1002/alz.12898

N/A

0.345DataRank · unranked

9 citations

Yann Cobigo, Patrick Callahan, Brian S. Appleby, Danielle Brushaber, Kimiko Domoto‐Reilly +26 more

Protocol for a seamless phase 2A-phase 2B randomized double-blind placebo-controlled trial to evaluate the safety and efficacy of benfotiamine in patients with early Alzheimer’s disease (BenfoTeam)

PLoS ONE(2024)10.1371/journal.pone.0302998

N/A

0.319DataRank · unranked

4 citations

José A. Luchsinger, Gabriel C. Léger, Curtis Taylor, Diane M. Jacobs, David P. Salmon +15 more

Prognostic value of plasma biomarkers for informing clinical trial design in mild-to-moderate Alzheimer’s disease

Alzheimer s Research & Therapy(2025)10.1186/s13195-025-01745-3

N/A

0.256DataRank · unranked

4 citations

Diane M. Jacobs, Karen Messer, David P. Salmon, Cheryl L. Wellington, Sophie Stukas +61 more

Gene-Specific Effects on Brain Volume and Cognition of TMEM106B in Frontotemporal Lobar Degeneration

Neurology(2024)10.1212/wnl.0000000000209832

N/A

0DataRank · unranked

7 citations

Eliana Marisa Ramos, Nick Corriveau‐Lecavalier, Vijay K. Ramanan, John Kornak, Carly Mester +50 more

ASLPrep: a platform for processing of arterial spin labeled MRI and quantification of regional brain perfusion

Nature Methods(2022)10.1038/s41592-022-01458-7

N/A

0DataRank · unranked

49 citations

Maxwell A. Bertolero, Sudipto Dolui, Matthew Cieslak, Kristin Murtha, Erica B. Baller +94 more

Psychotropic medication usage in sporadic versus genetic behavioral‐variant frontotemporal dementia

Alzheimer s & Dementia(2024)10.1002/alz.14448

N/A

0DataRank · unranked

1 citations

Nico Dimal, Kasey Cortez, Hilary W. Heuer, Leah K. Forsberg, Brian S. Appleby +32 more

Effects of exercise on cognition and Alzheimer's biomarkers in a randomized controlled trial of adults with mild cognitive impairment: The EXERT study

Alzheimer s & Dementia(2025)10.1002/alz.14586

N/A

0DataRank · unranked

22 citations

Judy Pa, Jeffrey A. Katula, Vahan Aslanyan, David P. Salmon, Diane M. Jacobs +22 more

Comparison of the telephone‐Montreal Cognitive Assessment (T‐MoCA) and Telephone Interview for Cognitive Status (TICS) as screening tests for early Alzheimer's disease

Alzheimer s & Dementia(2023)10.1002/alz.13039

N/A

0DataRank · unranked

27 citations

Christina Gigliotti, Gabriel C. Léger, Guerry M. Peavy, Diane M. Jacobs, Sarah J. Banks +4 more